U.S. FDA panel unanimously votes in favor of RSV antibody treatment for infants

FDA panel unanimously votes in favor of RSV antibody treatment for infants The Food and Drug Administration’s (FDA) antimicrobial drug advisory panel on Thursday voted unanimously in favor of approving a respiratory syncytial virus (RSV) treatment for infants, bring… jchoi The Hill

The Food and Drug Administration’s (FDA) antimicrobial drug advisory panel on Thursday voted unanimously in favor of approving a respiratory syncytial virus (RSV) treatment for infants, bringing the product closer to approval following the overwhelming surge in RSV cases that were seen last year in young children.

...